We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Guidance on Pharmacogenomics, Urges Firms to Submit Data
FDA Issues Guidance on Pharmacogenomics, Urges Firms to Submit Data
March 25, 2005
The FDA wants drugmakers to voluntarily submit pharmacogenomic data as part of an initiative to speed the development of personalized therapies based on patients’ genetic profiles, according to a new final guidance.